Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 30;127(7):2464-2472.
doi: 10.1172/JCI90594. Epub 2017 May 22.

Danger signals in regulating the immune response to solid organ transplantation

Affiliations
Review

Danger signals in regulating the immune response to solid organ transplantation

Jamie L Todd et al. J Clin Invest. .

Abstract

Endogenous danger signals, or damage-associated molecular patterns (DAMPs), are generated in response to cell stress and activate innate immunity to provide a pivotal mechanism by which an organism can respond to damaged self. Accumulating experimental and clinical data have established the importance of DAMPs, which signal through innate pattern recognition receptors (PRRs) or DAMP-specific receptors, in regulating the alloresponse to solid organ transplantation (SOT). Moreover, DAMPs may incite distinct downstream cellular responses that could specifically contribute to the development of allograft fibrosis and chronic graft dysfunction. A growing understanding of the role of DAMPs in directing the immune response to transplantation has suggested novel avenues for the treatment or prevention of allograft rejection that complement contemporary immunosuppression and could lead to improved outcomes for solid organ recipients.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: J.L. Todd discloses research support granted to the institution from Boehringer Ingelheim, GlaxoSmithKline, and Theravance Biopharma Inc. J.L. Todd has served in an advisory role for Therabron Therapeutics Inc. S.M. Palmer discloses research support granted to the institution from Boehringer Ingelheim and Gilead Sciences. S.M. Palmer has served in an advisory role for Boehringer Ingelheim, Chimerix, Renovion, Sofinnova Partners, and Therabron Therapeutics Inc. S.M. Palmer’s spouse is an employee of Lexicon.

Figures

Figure 1
Figure 1. Danger signals in solid organ transplantation (SOT).
In the context of SOT, DAMPs can accumulate in the donor organ during the process of donor brain death or as a result of IRI. DAMPs act through TLRs or DAMP-specific receptors to activate innate immunity and enhance the alloresponse by upregulating donor alloantigen presentation, providing costimulation to recipient T cells and driving effector T cell recruitment and differentiation. Cytotoxic T cells and donor-specific antibody generated from the alloresponse can cause acute allograft rejection, which may in turn cause sustained graft injury, thereby potentiating DAMP release. Evolving data suggest DAMPs may also directly promote fibrotic responses, thereby potentially contributing, along with alloimmunity, to the development of organ fibrosis and chronic graft dysfunction.

References

    1. Kim IK, Bedi DS, Denecke C, Ge X, Tullius SG. Impact of innate and adaptive immunity on rejection and tolerance. Transplantation. 2008;86(7):889–894. doi: 10.1097/TP.0b013e318186ac4a. - DOI - PubMed
    1. Thornley TB, et al. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol. 2006;176(3):1561–1570. doi: 10.4049/jimmunol.176.3.1561. - DOI - PMC - PubMed
    1. Chen L, et al. TLR engagement prevents transplantation tolerance. Am J Transplant. 2006;6(10):2282–2291. doi: 10.1111/j.1600-6143.2006.01489.x. - DOI - PubMed
    1. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045. doi: 10.1146/annurev.iy.12.040194.005015. - DOI - PubMed
    1. Wu H, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007;117(10):2847–2859. doi: 10.1172/JCI31008. - DOI - PMC - PubMed